XPRIZE Healthspan — Finals Phase
Funds teams developing therapeutics that improve longevity through practical medical research and validation.
XPRIZE Healthspan is a $101 million incentive prize competition launched in 2023 to accelerate the development of therapeutics that restore muscle, cognitive, and immune function by a minimum of 10 years — with a goal of 20 years — in adults aged 50 to 80. Treatment duration must be one year or less. The competition is co-titled by HEVOLUTION and SOLVE FSHD; GSK serves as a pharmaceutical industry…
Therapeutics that restore muscle, cognitive, and immune function by a minimum of 10 years (goal: 20 years) in adults aged 50–80; treatment duration ≤1 year. FSHD Bonus Track: substantially improve muscle function in facioscapulohumeral muscular dystrophy.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Sign up free to see how to apply
Sign up free to see what you submit
Sign up free to see the timeline